Thought Leadership
What High Court's Kisor Ruling Means for FDA Decisions
July 16, 2019
Chad Landmon
Law360

Axinn partner Chad Landmon authored the Law360 article, "What High Court's Kisor Ruling Means for FDA Decisions."

Click here to access the article. A subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.